Abstract |
To date, two positron emission tomography (PET) studies have explored 5-HT(1A) receptor density in the hippocampus of Alzheimer's disease (AD) patients. They showed early changes of 5-HT(1A) receptors in this brain region, known to have a dense serotonergic innervation. These studies only reported measurements in hippocampus. In the present PET study, we used an antagonist of 5-HT(1A) receptors, the [(18)F]MPPF (1) to explore 5-HT(1A) receptor density in the whole brain of AD patients at a mild stage of dementia and amnestic mild cognitive impairment (aMCI) patients compared to a control population; (2) to explore more precisely the 5-HT(1A) receptor density in the limbic brain regions of AD patients and aMCI patients compared to controls. Voxel-based analyses were performed to assess differences in the [(18)F]MPPF binding potential (BP) between AD patients and aMCI patients compared to controls. Analyses of whole-brain [(18)F]MPPF BP showed a global decrease in AD brains in contrast with a global increase in aMCI brains. In AD brains, a significant decrease of BP was detected in hippocampus and parahippocampal gyrus, whereas a significant increase of BP was observed in the inferior occipital gyrus in aMCI brains. These whole brain results are in accordance to hippocampal data reported in a previous study, showing an increase of [(18)F]MPPF binding in the aMCI group contrasting with a decrease in the AD group. Altogether, these results suggest the implication of a compensatory mechanism illustrated by an up regulation of serotonergic metabolism at the aMCI stage before a breakdown of this mechanism at the AD stage. This difference of serotonergic receptor labeling allows to distinguish the groups of aMCI patients from mild AD patients with specific [(18)F]MPPF PET profiles for each patient group.
|
Authors | L Truchot, N Costes, L Zimmer, B Laurent, D Le Bars, C Thomas-Antérion, B Mercier, M Hermier, A Vighetto, P Krolak-Salmon |
Journal | NeuroImage
(Neuroimage)
Vol. 40
Issue 3
Pg. 1251-6
(Apr 15 2008)
ISSN: 1053-8119 [Print] United States |
PMID | 18313943
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Piperazines
- Pyridines
- Radiopharmaceuticals
- Receptor, Serotonin, 5-HT1A
- 4-(2'-methoxyphenyl)-1-(2'-(N-2'-pyridinyl)-p-(18F)fluorobenzamido )ethylpiperazine
|
Topics |
- Aged
- Alzheimer Disease
(diagnostic imaging, psychology)
- Amnesia
(diagnostic imaging, psychology)
- Brain
(diagnostic imaging)
- Cognition Disorders
(diagnostic imaging, psychology)
- Female
- Functional Laterality
(physiology)
- Humans
- Image Processing, Computer-Assisted
- Limbic System
(diagnostic imaging)
- Male
- Middle Aged
- Piperazines
- Positron-Emission Tomography
- Pyridines
- Radiopharmaceuticals
- Receptor, Serotonin, 5-HT1A
(metabolism)
|